mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.02 |